HomeCompareIVSX vs KMB

IVSX vs KMB: Dividend Comparison 2026

IVSX yields 8.58% · KMB yields 5.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KMB wins by $10.6K in total portfolio value· pulled ahead in Year 6
10 years
IVSX
IVSX
● Live price
8.58%
Share price
$23.30
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$35.3K
Annual income
$1,475.66
Full IVSX calculator →
KMB
KMB
● Live price
5.25%
Share price
$96.35
Annual div
$5.06
5Y div CAGR
17%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.9K
Annual income
$5,222.34
Full KMB calculator →

Portfolio growth — IVSX vs KMB

📍 KMB pulled ahead of the other in Year 6

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIVSXKMB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IVSX + KMB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IVSX pays
KMB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IVSX
Annual income on $10K today (after 15% tax)
$729.49/yr
After 10yr DRIP, annual income (after tax)
$1,254.31/yr
KMB
Annual income on $10K today (after 15% tax)
$446.39/yr
After 10yr DRIP, annual income (after tax)
$4,438.99/yr
At 15% tax rate, KMB beats the other by $3,184.68/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IVSX + KMB for your $10,000?

IVSX: 50%KMB: 50%
100% KMB50/50100% IVSX
Portfolio after 10yr
$40.6K
Annual income
$3,349.00/yr
Blended yield
8.25%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KMB right now

IVSX
No analyst data
KMB
Analyst Ratings
9
Buy
19
Hold
3
Sell
Consensus: Hold
Price Target
$123.00
+27.7% upside vs current
Range: $102.00 — $162.00
Altman Z
3.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IVSX buys
0
KMB buys
0
No recent congressional trades found for IVSX or KMB in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIVSXKMB
Forward yield8.58%5.25%
Annual dividend / share$2.00$5.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17%
Portfolio after 10y$35.3K$45.9K
Annual income after 10y$1,475.66$5,222.34
Total dividends collected$11.7K$21.6K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: IVSX vs KMB ($10,000, DRIP)

YearIVSX PortfolioIVSX Income/yrKMB PortfolioKMB Income/yrGap
1$11,558$858.22$11,314$614.45+$244.00IVSX
2$13,294$927.05$12,867$760.19+$427.00IVSX
3$15,221$996.55$14,713$945.27+$508.00IVSX
4$17,353$1,066.36$16,924$1,181.90+$429.00IVSX
5$19,704$1,136.18$19,596$1,486.64+$108.00IVSX
6← crossover$22,289$1,205.70$22,850$1,882.16$561.00KMB
7$25,124$1,274.65$26,849$2,399.80$1.7KKMB
8$28,226$1,342.77$31,812$3,083.36$3.6KKMB
9$31,611$1,409.84$38,033$3,994.72$6.4KKMB
10$35,300$1,475.66$45,918$5,222.34$10.6KKMB

IVSX vs KMB: Complete Analysis 2026

IVSXStock

IVSX uses proprietary valuation models in researching small- and mid-cap companies in developed markets outside of North America, aiming for growth through fundamental analysis. The funds adviser uses proprietary research, valuation models, and its Intrinsic Value Stewardship (IVS) model to select stocks with strong return potential, considering factors like valuation, growth, profitability, and business strategy. The Fund is actively managed, typically holds at least 150 positions across multiple countries and sectors, but may concentrate more on certain holdings if justified by its research. The adviser sells positions if they no longer offer compelling investment opportunities or become too large relative to the portfolio.

Full IVSX Calculator →

KMBConsumer Staples

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Full KMB Calculator →
📬

Get this IVSX vs KMB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IVSX vs SCHDIVSX vs JEPIIVSX vs OIVSX vs KOIVSX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.